| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > A Study Of Lesbian Women Suggests A Possible Genetic Cause For Obesity |
|
E-Articles - A Study Of Lesbian Women Suggests A Possible Genetic Cause For Obesity
Obesity is continuing to rise at alarming rates in many western countries and there can be very According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product little doubt that our modern lifestyle and diet is to a very large extent responsible for what h ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in as now been officially classed as an epidemic. However, there is also a small but growing school lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of thought which holds that increasing obesity is also to a certain extent genetic. At this po here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe int in time there is little evidence to support a genetic component to obesity and it is not rea d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lly possible to draw any firm conclusions. However, one recent interesting development may add s ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ome validity to the genetic argument. In a national study of nearly 6,000 women it was found th easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi at lesbian women were nearly three times more likely to be overweight than heterosexual women an nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically d were also nearly two and a half times more likely to be obese. These finding were surprising and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ as the study also noted that in general lesbian women had a better image of their bodies than he ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi terosexual women and also tended to take more formal exercise. One argument put forward in an ef ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a fort to discount the findings of this study suggested that lesbian women were more muscular than dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod heterosexual women and that this accounted for their higher body mass index (BMI). However, thi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s was ruled out as, although high muscular weight and low body fat can produce a deceptively hig tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen h BMI reading, this was taken into account during the study and the readings were adjusted accor t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel dingly. So what is the explanation? Well, the simple answer is that we don't know. However, th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ere is increasingly strong evidence to support a genetic link to sexuality and one suggestion th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products erefore is that, in the absence of any other explanation, perhaps the propensity for obesity is . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de also genetic. Only time and further research will answer this question but, in the meantime, le elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip sbian women should be made aware of the fact that they are at greater risk of developing obesity tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Cure the 5 Most Costly Problems of Vacant Houses
|